Skip to content

ASCENTAGE PHARMA GROUP INTERNATIONAL

AAPG

CIK 0002023311

← back to feed
Revenue (TTM)
¥134.35M
−39.5% YoY FY Apr 2026
Net Income (TTM)
−¥55.58M
+94.0% YoY FY Apr 2026
EPS Diluted (TTM)
−¥0.18
+94.5% YoY FY Apr 2026
Gross Margin
97.0%
FY Apr 2026
Operating Margin
—
FY Apr 2026
Net Margin
-41.4%
FY Apr 2026
Free Cash Flow (TTM)
—
FY Apr 2026
Cash
¥122.35M
FY Apr 2026
Total Debt
—
FY Apr 2026
Shares Outstanding
373.32M sh
FY Apr 2026

Revenue & Net Income

EPS (Diluted)

Margins

Cash Flow

Revenue Growth (YoY)

Cash vs Debt

Recent filings